Profile data is unavailable for this security.
About the company
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
- Revenue in USD (TTM)15.12bn
- Net income in USD1.47bn
- Incorporated2022
- Employees21.78k
- LocationKenvue Inc1 Kenvue WaySUMMIT 07901United StatesUSA
- Phone+1 (908) 874-1200
- Fax+1 (302) 655-5049
- Websitehttps://www.kenvue.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clorox Co | 6.76bn | 755.00m | 14.65bn | 7.60k | 19.79 | -- | 14.75 | 2.17 | 6.12 | 6.12 | 54.86 | -1.03 | 1.21 | 6.29 | 10.61 | 889,210.50 | 13.76 | 8.20 | 22.68 | 12.15 | 44.16 | 41.41 | 11.39 | 6.85 | 0.4772 | 14.71 | 0.9876 | 121.61 | 0.1551 | 1.11 | 189.29 | -2.91 | -2.83 | 2.85 |
| Church & Dwight Co Inc | 6.20bn | 736.80m | 24.38bn | 5.55k | 34.21 | 6.09 | 24.78 | 3.93 | 3.01 | 3.01 | 25.39 | 16.92 | 0.6972 | 5.97 | 10.39 | 1,117,694.00 | 8.28 | 7.91 | 9.84 | 9.62 | 44.73 | 44.16 | 11.88 | 11.55 | 0.7092 | 16.89 | 0.3552 | 40.17 | 1.57 | 4.85 | 25.88 | -1.28 | 4.36 | 4.43 |
| Kimberly-Clark Corp | 17.23bn | 1.63bn | 34.73bn | 36.00k | 21.42 | 23.12 | 15.33 | 2.02 | 4.89 | 6.06 | 51.72 | 4.53 | 1.02 | 6.60 | 9.59 | 478,694.40 | 8.68 | 9.41 | 15.17 | 15.94 | 36.91 | 34.66 | 8.47 | 9.10 | 0.5383 | 12.23 | 0.8152 | 90.06 | -2.13 | -2.99 | -29.37 | -8.30 | -1.33 | -2.27 |
| Kenvue Inc | 15.12bn | 1.47bn | 34.79bn | 21.78k | 23.76 | 3.23 | 17.16 | 2.30 | 0.7639 | 0.7639 | 7.86 | 5.62 | 0.5742 | 3.84 | 6.65 | 694,398.50 | 5.58 | 6.07 | 7.17 | 7.49 | 58.62 | 57.28 | 9.72 | 10.93 | 0.678 | 7.08 | 0.4419 | 46.94 | -2.14 | 0.8922 | 42.72 | -- | 15.71 | -- |
| Estee Lauder Companies Inc | 14.67bn | -150.00m | 35.71bn | 57.00k | -- | 8.86 | 54.02 | 2.43 | -0.4235 | -0.5003 | 40.46 | 11.15 | 0.7447 | 1.93 | 8.98 | 257,333.30 | -0.7615 | 5.21 | -1.03 | 7.34 | 74.33 | 73.89 | -1.02 | 6.98 | 0.9985 | 5.88 | 0.6449 | 74.29 | -8.24 | 0.0405 | -390.51 | -- | -0.6834 | 4.23 |
| Colgate-Palmolive Co | 20.38bn | 2.13bn | 76.56bn | 33.60k | 36.43 | 1,417.16 | 26.49 | 3.76 | 2.62 | 2.62 | 25.14 | 0.0674 | 1.26 | 4.05 | 12.75 | 606,607.10 | 13.96 | 15.21 | 23.64 | 22.62 | 60.11 | 59.12 | 11.09 | 12.66 | 0.5366 | 22.64 | 0.9563 | 74.31 | 1.40 | 4.35 | -26.20 | -4.58 | 6.59 | 3.32 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 215.61m | 11.25% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 118.87m | 6.20% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 95.38m | 4.98% |
| Pentwater Capital Management LPas of 31 Dec 2025 | 56.72m | 2.96% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 51.92m | 2.71% |
| Geode Capital Management LLCas of 31 Dec 2025 | 49.86m | 2.60% |
| Independent Franchise Partners LLPas of 31 Dec 2025 | 48.15m | 2.51% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 45.38m | 2.37% |
| Norges Bank Investment Managementas of 31 Dec 2025 | 43.88m | 2.29% |
| UBS Securities LLCas of 31 Dec 2025 | 40.81m | 2.13% |
